Nobel Prize-winning discoveries launched Geron's mission to change lives by changing the course of blood cancer.
An updated website was designed to bring their latest product to market. It offers an editorial driven experience that showcases their leading manufacturing, human resources, and communications customimzed for investors, and partners to maximize impact, and value.
The brand, typography, and tone were also enhanced to reflect Geron's bold nature. Custom graphics were designed to elevate their pipeline, as well as support key industry events to inspire new levels of awareness, and engagement.
FDA approved RYTELO on June 6, 2024
Animation was designed to explain how Telomerase operates in the bloodstream. The final video was used to showcase these advancements to investors, and the media, as well as event experiences. R&D Pipeline was reimagined to smoothly flow between the desktop, tablets, and mobile.
